Development and validation of the Nightingale Symptom Assessment Scale (N-SAS) and predictors of the quality of life of the cancer patients in Turkey
EUROPEAN JOURNAL OF ONCOLOGY NURSING, cilt.15, sa.1, ss.3-11, 2011 (SCI-Expanded, SSCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 15 Sayı: 1
- Basım Tarihi: 2011
- Doi Numarası: 10.1016/j.ejon.2009.10.010
- Dergi Adı: EUROPEAN JOURNAL OF ONCOLOGY NURSING
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
- Sayfa Sayıları: ss.3-11
- Anahtar Kelimeler: Cancer patient, Quality of life, Chemotherapy, Biotherapy, Side effects, Cancer, Scale, Instrument, BREAST-CANCER, SOCIAL SUPPORT, TURKISH PATIENTS, ONCOLOGY, CHEMOTHERAPY, QLQ-C30, TRIAL
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır
Özet
Purpose: Treatment-related side effects have an adverse impact on the health-related quality of life (HRQoL) of cancer patients undergoing chemotherapy. This study is a description of the validity and responsiveness demonstrated by a new cancer and cancer treatment-specific symptom scale - the Nightingale Symptom Assessment Scale (N-SAS) - which was developed and validated to address the QoL of Turkish cancer patients.